Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-183-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 268, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
HIC2 hsa-miR-183-3p low: 0 high: 2 2 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:21451338-21451365 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:21449439-21449455 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RUFY2 hsa-miR-183-3p low: 0 high: 2 2 2 2 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr10:68345000-68345015 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:68345340-68345361 PAR-CLIP POSITIVE DIRECT TarBase 7.0
UBE3C hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:157248586-157248605 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:157248586-157248605 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNF11 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:51271826-51271847 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:51271826-51271847 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF117 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:64978926-64978952 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr7:64977750-64977776 PAR-CLIP POSITIVE DIRECT TarBase 7.0
LIN28B hsa-miR-183-3p low: 0 high: 2 1 1 1 0.707
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:105080832-105080849 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:105080832-105080849 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF257 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:22089589-22089606 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr19:22089420-22089440 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ZNF43 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:21808189-21808214 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr19:21807685-21807710 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SMIM13 hsa-miR-183-3p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:11138605-11138631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:11138605-11138631 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:92609109-92609130 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KMT2E hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:105112184-105112206 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RNF14 hsa-miR-183-3p low: 0 high: 1 1 1 1 0.520
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:141974909-141974924 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SLAMF7 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:160753227-160753255 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CENPQ hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:49492191-49492213 PAR-CLIP POSITIVE DIRECT TarBase 7.0
FAM214A hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:52609811-52609828 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SNX29 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:12572969-12572991 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RSF1 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:77665517-77665534 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WNK1 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr12:884899-884919 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NCKAP1 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:182925505-182925530 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNF4 hsa-miR-183-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr4:2515243-2515263 HITS-CLIP POSITIVE DIRECT TarBase 7.0